05:52 PM EDT, 08/26/2024 (MT Newswires) -- Lifecore Biomedical ( LFCR ) reported a fiscal Q4 net loss from continuing operations late Monday of $7.09 million, compared with the loss of $37 million a year earlier.

Revenue in the quarter ended May 26 rose to $37.9 million from $31.1 million a year earlier.

Two analysts surveyed by Capital IQ expected $36.4 million.

In fiscal 2025, the company expects revenue of $126.5 million to $130 million.

Two analysts polled by Capital IQ expect $142 million.

Price: 6.35, Change: +0.01, Percent Change: +0.16